Article
Molecular pharmacology of selective NaV1.6 and dual NaV1.6 and NaV1.2 channel inhibitors…
medRxiv · 2023 · Goodchild, S. J.; Shuart, N. G.; Williams, A. D.; Ye, W.; Parrish, R. R.; Soriano, M.; Thouta, S.; Mezeyova, J.; Waldbrook, M.; Dean, R. A.; Focken, T.; Ghovanloo, M.-R.; Ruben, P. C.; Scott, F.; Cohen, C. J.; Empfield, J. R.; Johnson, J.
Key facts
| Title | Molecular pharmacology of selective NaV1.6 and dual NaV1.6 and NaV1.2 channel inhibitors that suppress excitatory neuronal activity ex vivo |
|---|---|
| First author | Goodchild, S. J.; Shuart, N. G.; Williams, A. D.; Ye, W.; Parrish, R. R.; Soriano, M.; Thouta, S.; Mezeyova, J.; Waldbrook, M.; Dean, R. A.; Focken, T.; Ghovanloo, M.-R.; Ruben, P. C.; Scott, F.; Cohen, C. J.; Empfield, J. R.; Johnson, J. |
| Journal | medRxiv |
| Published | Aug 7, 2023 |
| DOI | 10.1101/2023.08.03.551643 |
| Devices mentioned | 006920, 021007 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1